The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent

INTRODUCTION: Fluoropyrimidines, principally 5-fluorouracil (5-FU), remain a key component of chemotherapy regimens for multiple cancer types, in particular colorectal and other gastrointestinal malignancies. To overcome key limitations and pharmacologic challenges that hinder the clinical utility o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bré, Jennifer, Dickson, Alison L., Read, Oliver J., Zhang, Ying, McKissock, Fiona G., Mullen, Peter, Tang, Peijun, Zickuhr, Greice M., Czekster, Clarissa M., Harrison, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156769/
https://www.ncbi.nlm.nih.gov/pubmed/37000221
http://dx.doi.org/10.1007/s00280-023-04528-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156769/
https://www.ncbi.nlm.nih.gov/pubmed/37000221
http://dx.doi.org/10.1007/s00280-023-04528-5

Ejemplares similares